Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Wyeth is now a wholly owned subsidiary of Pfizer
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males or females, 18 -65 years of age
Outpatients
Major depressive disorder based on DSM-IV criteria
The baseline score of 17-item HAM-D³17
Switchers from prior antidepressants, who have had no satisfactory improvement (normally after a minimum of 8weeks of treatment), with an approved antidepressant medication or have experienced intolerance due to side effects to their antidepressant medication based on clinical discretion
Provide written informed consent
If female is of childbearing potential, must be confirmed no pregnancy at baseline, and use a medically acceptable method of contraception throughout the study.
You may not be if
Hypersensitivity to venlafaxine;
Clinically significant renal or hepatic disease or any other medical disease that, in the opinion of the investigator, might compromise the study, including seizure
Alcohol or drug abuse within the last year
A recent history of myocardial infarction or unstable heart disease (within 6 months of baseline)
Bipolar disorder
For female, known or suspected pregnancy or breast feeding
Use of a monoamine oxidase inhibitor (MAOI) within 14 days of baseline; use of any investigational drug within 30 days of baseline.
Patients have prior use of venlafaxine or use of venlafaxine for the current episode.
Clareo Health | Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
